Crossmark

Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation

Crossref DOI link: https://doi.org/10.1038/s41409-019-0730-y

Published Online: 2019-10-29

Published Print: 2020-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharma, Prashant

Gakhar, Neel

MacDonald, Jennifer

Abidi, Maheen Z.

Benamu, Esther

Bajrovic, Valida

Purev, Enkhtsetseg

Haverkos, Bradley M. https://orcid.org/0000-0003-0056-6023
Tobin, Jennifer

Kaiser, Jeff

Chase, Stephanie

Miller, Matthew

Weinberg, Adriana

Gutman, Jonathan A.
License Information

Text and Data Mining valid from 2019-10-29

Version of Record valid from 2019-10-29
More Information

Article History

Received: 9 August 2019

Revised: 9 October 2019

Accepted: 16 October 2019

First Online: 29 October 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below